Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Rhea-AI Summary

Spruce Biosciences, Inc. (SPRB) will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 13, 2024. The CEO will discuss the development and commercialization of novel therapies for rare endocrine disorders. The live webcast can be accessed on the company's investor relations website, with an archived copy available for 90 days.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Oppenheimer 34^th Annual Healthcare Life Sciences Conference on February 13, 2024 at 2:40 p.m. ET.

Interested parties can access the live webcast here. An archived copy of the webcast will be available on the events section of the company’s investor relations website for approximately 90 days.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal, once-daily therapy for patients suffering from classic congenital adrenal hyperplasia (CAH) and other endocrine disorders. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240130180434/en/

Media Contact

Will Zasadny

Inizio Evoke Comms

(619) 961-8848

will.zasadny@inizioevoke.com

media@sprucebio.com

Investors

Samir Gharib

President and CFO

Spruce Biosciences, Inc.

investors@sprucebio.com

Source: Spruce Biosciences, Inc.

FAQ

When will Spruce Biosciences present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference?

Spruce Biosciences will present on February 13, 2024 at 2:40 p.m. ET.

What is the focus of Spruce Biosciences?

Spruce Biosciences is focused on developing and commercializing novel therapies for rare endocrine disorders.

Where can the live webcast be accessed?

The live webcast can be accessed on the company's investor relations website.

How long will the archived copy of the webcast be available?

The archived copy will be available for approximately 90 days on the events section of the company’s investor relations website.